Olivier Legrain
About Olivier Legrain
Olivier Legrain serves as the Chief Executive Officer of IBA, a position he has held since May 2012. He has extensive experience within the company, having previously worked as Chief Strategy Officer and President of IBA Molecular, and he has been a member of the IBA Board of Directors since 2012.
Current Role at IBA
Olivier Legrain serves as the Chief Executive Officer of IBA, a position he has held since May 2012. In this role, he oversees the strategic direction and operational management of the company. Legrain has led several Business Units within the IBA Group, contributing to the company's growth and innovation in the field of radiation therapy and medical technology. His leadership has been instrumental in advancing IBA's mission to improve patient care through cutting-edge solutions.
Previous Positions at IBA
Before becoming CEO, Olivier Legrain held various key positions at IBA. He served as Chief Strategy Officer from 2011 to 2012 and as Chief Operating Officer prior to that. His tenure at IBA began in 1996 when he joined as Group Controller, a role he held for five years. He also served as President of IBA Molecular from 2003 to 2010. These roles provided him with extensive experience in strategic planning and operational management within the organization.
Experience at Amaris
Olivier Legrain worked at Amaris as a Captain for a period of ten months from 2010 to 2011. This role allowed him to gain additional experience in project management and leadership in a consulting environment, further enhancing his skills in strategic oversight and operational execution.
Educational Background
Olivier Legrain studied at College Cardinal Mercier. His educational background has provided a foundation for his career in management and leadership within the technology and healthcare sectors.
Board Membership and Committees
Since May 2012, Olivier Legrain has been a member of the IBA Board of Directors. He is an Internal Director and participates in several committees, including the Nomination Committee, Product Committee, and Sustainability Committee. His involvement in these committees reflects his commitment to governance and strategic development within the organization.